Vaccine Capabilities Protein Sciences specializes in vaccine development and protein production using BEVS technology, presenting opportunities to position for partnerships in next generation vaccines and recombinant protein products across research institutions and biotech firms seeking scalable vaccine platforms.

BEVS Expertise Leverage their proprietary BEVS expression system to offer contract development and manufacturing services, especially for clients aiming to accelerate timelines for vaccines, therapeutics, and gene therapies.

Cooperative Programs Current collaborations with research and industry players (e.g., university partnerships and international licensing for influenza vaccines) indicate potential for channel partnerships, licensing deals, and joint development opportunities in regional markets.

Product Portfolio Three-focused lines — proprietary vaccines, GeneXpress development/manufacturing services, and research antigens — suggest cross-sell opportunities to customers needing comprehensive vaccine workflows, from antigens to finished products.

Growth & Outreach Recent initiatives like the CIPPS center and regional licensing efforts point to expansion plans and market-entry opportunities; target institutions and manufacturers seeking innovation in protein-based solutions and scalable production.